Suivez en direct la cotation de l'action ACASTI PHARMA INC à la Bourse de Paris, découvrez les analyses, les recommandations et toute l'actualité de Acasti

ACST, Acasti Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Acasti Pharma Inc Stock Quote: ACST Stock News, Quotes, Analysis | Investors.com

Free real-time prices, trades, and chat. Acasti Pharma is advancing a potentially best-in-class omega-3 therapeutic for the treatment of hypertriglyceridemia. Our Science Sourced from krill, CaPre® is designed to deliver a trifecta of cardiometabolic health benefits to patients in need. Recently in News on March 8, 2021, Acasti Pharma Provides Update on Recent Financing Activities. As required pursuant to the policies of the TSX Venture Exchange, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) is providing an update on the use of its “at-the market” equity offering program.

Acasti Pharma Announces Results for Third Quarter of Fiscal 2021. February 9, 2021. View All News. Email Alerts.

ACST | Complete Acasti Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

2020-11-18 2021-02-09 2021-02-23 Acasti Pharma Inc is a biopharmaceutical innovator advancing a cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population. Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the… The latest news and upcoming dividend, earnings, and split events for Acasti Pharma Inc. (ACST). A high-level overview of Acasti Pharma Inc. (ACST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Cours Action ACASTI PHARMA INC (ACST) CA00430K4028 et les informations boursières de la cotation sur le marché NASDAQ CAPITAL MARKET. Séance

Köp aktien Acasti Pharma, Inc. - Class A Common Stock (ACST). Hos Nordnet kan du handla från 0 kr i courtage.

2020 — Feedback Forum · Earnings News (SKVKY)By: Meghavi Singh, SA News Editor. Skandinaviska ACSTAcasti Pharma Inc. 0.43. Post. 0.38. 14 jan.
Concept smart car

The company report on March 9, 2021 that Acasti Pharma Provides Update on Recent Financing Activities. Get the hottest stocks to trade every Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM Acasti Pharma Inc. (NASDAQ:ACST)’s traded shares stood at 10,888,114 during the last session, with the company’s beta value hitting 0. At the close of trading, the stock’s price was $0.46, to imply an increase of 9.68% or $0.04 in intraday trading. The ACST share’s 52-week high remains $1.22 Acasti Pharma news and ACST price.

Free real-time prices, trades, and chat.
Infomentor leksand logga in

varför vill barn prata med bris
kryptovalutor lista
autism diagnos vuxen
zombie 1994
lediga jobb mcdonalds stockholm
hur många procent av sveriges befolkning röker

The latest news and upcoming dividend, earnings, and split events for Acasti Pharma Inc. (ACST).

ACST | Complete Acasti Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Acasti Pharma Inc is a biopharmaceutical innovator advancing a cardiovascular drug, CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population.

Acasti Pharma News: This is the News-site for the company Acasti Pharma on Markets Insider 2021-03-09 · The stock of Acasti Pharma (NASDAQ: ACST) increased by 16.75% on Tuesday before the opening bell. The rise followed a decline of -0.84% or -$0.01 per share in regular session and an update on the use of the company’s equity offering. 2021-03-31 · View the latest Acasti Pharma Inc. (ACST) stock price, news, historical charts, analyst ratings and financial information from WSJ. Acasti Pharma Inc. ("Acasti or the "Company") (NASDAQ: ACST - TSX-V: ACST) today announced its operating and financial results for the third quarter of fiscal 2021 ended December 31, 2020. Acasti Pharma News: This is the News-site for the company Acasti Pharma on Markets Insider 2021-04-19 · Acasti Pharma Inc., which has a market valuation of $81.45 Million, is expected to release its quarterly earnings report in Jun 2021.

Meanwhile, Acasti Pharma initiates a review process to evaluate strategic alternatives to boost shareholder value. Acasti Pharma Inc. NASDAQ Updated Apr 16, 2021 11:54 PM ACST 0.41 0.03 (7.16%). Post-Market 0.01 (3.15%) With its current market valuation of $117.93 Million, Acasti Pharma Inc. is set to declare its quarterly results next month.